Establishment of coculture model of blood-brain barrier in vitro for nanoparticle's transcytosis and toxicity evaluation
- PMID: 16856472
Establishment of coculture model of blood-brain barrier in vitro for nanoparticle's transcytosis and toxicity evaluation
Abstract
Aim: A method of coculture of brain capillary endothelial cells (BCECs) and astrocytes of rats was used to evaluate nanoparticle's blood-brain barrier (BBB) transcytosis and toxicity at the endothelial tight junction.
Methods: A lipophilic fluorescent probe, 6-coumarin, was incorporated in poly (ethyleneglycol)-poly (lactide) nanoparticle using double emulsion/solvent evaporation method. BCECs and astrocytes were firstly isolated from brain of newborn rats and characterized by their morphology and immunocytochemistry staining, separately. Subsequently, a coculture model with BCECs on the top of micro-porous membrane of cell culture insert and astrocytes on the bottom side was established. The permeability of 14C-labeled sucrose and nanoparticle were determined, separately.
Results: The mean weight-based diameter of 6-coumarin loaded nanoparticles was (102.4 +/- 6.8) nm, with zeta potential of (-16.81 +/- 1.05) mV. BCECs were positive for factor VIII staining and glial fibrillary acidic protein was expressed in astrocytes. The transendothelial electrical resistance reached up to (313 +/- 23) omega x cm2. The tight junction between BCECs in the coculture model could be visualized by both scanning electron microscopy and transmission electron microscopy. The unchanged paracellular transport of sucrose proved that nanoparticle with concentration lower than 200 microg x mL(-1) did not impact the integrity of BBB endothelial tight junctions. The permeability of 10 microg x mL(-1) 6-coumarin labeled nanoparticle was 0.29 x 10(-3) cm x min(-1).
Conclusion: This in vitro experimental model of rat BBB was close to resemble the in vivo situation for examination of the permeability of nanoparticle and toxicity evaluation.
Similar articles
-
Cationic albumin conjugated pegylated nanoparticle with its transcytosis ability and little toxicity against blood-brain barrier.Int J Pharm. 2005 May 13;295(1-2):247-60. doi: 10.1016/j.ijpharm.2005.01.043. Int J Pharm. 2005. PMID: 15848009
-
A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes.Neurochem Int. 2009 Mar-Apr;54(3-4):253-63. doi: 10.1016/j.neuint.2008.12.002. Epub 2008 Dec 7. Neurochem Int. 2009. PMID: 19111869
-
Brain delivery property and accelerated blood clearance of cationic albumin conjugated pegylated nanoparticle.J Control Release. 2007 Mar 12;118(1):38-53. doi: 10.1016/j.jconrel.2006.11.015. Epub 2006 Nov 24. J Control Release. 2007. PMID: 17240471
-
Brain endothelial cells and the glio-vascular complex.Cell Tissue Res. 2009 Jan;335(1):75-96. doi: 10.1007/s00441-008-0658-9. Epub 2008 Jul 16. Cell Tissue Res. 2009. PMID: 18633647 Review.
-
Blood-brain barrier biology and methodology.J Neurovirol. 1999 Dec;5(6):556-69. doi: 10.3109/13550289909021285. J Neurovirol. 1999. PMID: 10602397 Review.
Cited by
-
Targeting Malignant Brain Tumors with Antibodies.Front Immunol. 2017 Sep 25;8:1181. doi: 10.3389/fimmu.2017.01181. eCollection 2017. Front Immunol. 2017. PMID: 28993773 Free PMC article. Review.
-
Methodologies to assess drug permeation through the blood-brain barrier for pharmaceutical research.Pharm Res. 2013 Nov;30(11):2729-56. doi: 10.1007/s11095-013-1119-z. Epub 2013 Jun 26. Pharm Res. 2013. PMID: 23801086 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous